- Home
- ARWR vs GTLS Comparison
ARWR vs GTLS Comparison
Compare ARWR & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | GTLS |
|---|---|---|
| Founded | 2003 | 1859 |
| Country | United States | United States |
| Employees | N/A | 11777 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 10.0B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | GTLS |
|---|---|---|
| Price | $77.64 | $207.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 8 |
| Target Price | $83.40 | ★ $205.67 |
| AVG Volume (30 Days) | ★ 1.5M | 1.0M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | $14.31 |
| Revenue Next Year | N/A | $5.89 |
| P/E Ratio | ★ N/A | $240.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.30 | $141.47 |
| 52 Week High | $82.26 | $208.77 |
Technical Indicators
Market Signals| Indicator | ARWR | GTLS |
|---|---|---|
| Relative Strength Index (RSI) | 56.42 | 52.35 |
| Support Level | $70.49 | $206.59 |
| Resistance Level | $82.26 | $208.51 |
| Average True Range (ATR) | 3.69 | 0.47 |
| MACD | -0.19 | 0.05 |
| Stochastic Oscillator | 66.36 | 45.15 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.